Thomas Jenene D. 4
4 · UNIGENE LABORATORIES INC · Filed Jan 17, 2012
Insider Transaction Report
Form 4
Thomas Jenene D.
VP of Investor Relations
Transactions
- Award
Stock Option
2012-01-13+10,125→ 383,325 totalExercise: $0.65From: 2012-12-31Exp: 2022-01-12→ common stock (10,125 underlying) - Award
Stock Option
2012-01-13+43,200→ 373,200 totalExercise: $0.65From: 2012-12-31Exp: 2022-01-12→ common stock (43,200 underlying)